Exact Sciences Soars 10.75% on Q1 Earnings Beat
Generated by AI AgentAinvest Movers Radar
Friday, May 2, 2025 6:55 am ET1min read
EXAS--
Exact Sciences' stock surged 10.75% in pre-market trading on May 2, 2025, driven by strong Q1 earnings and raised guidance.
Exact Sciences Corporation reported a 10.9% year-on-year increase in revenue for the first quarter of 2025, surpassing Wall Street's expectations. The company's sales reached $706.8 million, with a notable 14% growth in screening services. This positive performance was highlighted during the company's live Q1 2025 earnings call on May 1, 2025, where management also announced the launch of a revolutionary cancer detection tool. The company's strong financial results and innovative product offerings have contributed to the stock's recent surge.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet